Glenn Pierce

Glenn F.
Pierce is currently Director at World Federation of Hemophilia since 2015, Independent Director at Voyager Therapeutics, Inc. since 2022, Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc. since 2009, and a Member of the American Society of Hematology, The International Society On Thrombosis & Haemostasis, and Hemostasis & Thrombosis Research Society.
Former roles include Independent Director at Global Blood Therapeutics, Inc. from 2016 to 2022, Principal at Amgen, Inc., Vice President-Research & Clinical Development at Avigen, Inc., Chief Medical Officer & SVP-Global Medical Affairs at Biogen, Inc. from 2013 to 2014, Vice President-Applied Research Hematology at Bayer Healthcare LLC, Vice President-PreClinical Development at Prizm Pharmaceuticals, Inc. in 1998, Vice President-Therapeutic Product Development at Selective Genetics, Inc. in 2002, President of the National Hemophilia Foundation, and Chief Medical Officer at Ambys Medicines, Inc. from 2018 to 2020.
Education includes graduate studies at Washington University in St. Louis and undergraduate and doctorate degrees from Case Western Reserve University.